Literature DB >> 32997525

Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease.

Silvestro Ennio D'Anna1, Mauro Maniscalco1, Francesco Cappello2,3, Mauro Carone4, Andrea Motta5, Bruno Balbi6, Fabio L M Ricciardolo7, Gaetano Caramori8, Antonino Di Stefano6.   

Abstract

In chronic obstructive pulmonary disease (COPD) patients, bacterial and viral infections play a relevant role in worsening lung function and, therefore, favour disease progression. The inflammatory response to lung infections may become a specific indication of the bacterial and viral infections. We here review data on the bacterial-viral infections and related airways and lung parenchyma inflammation in stable and exacerbated COPD, focussing our attention on the prevalent molecular pathways in these different clinical conditions. The roles of macrophages, autophagy and NETosis are also briefly discussed in the context of lung infections in COPD. Controlling their combined response may restore a balanced lung homeostasis, reducing the risk of lung function decline. KEY MESSAGE Bacteria and viruses can influence the responses of the innate and adaptive immune system in the lung of chronic obstructive pulmonary disease (COPD) patients. The relationship between viruses and bacterial colonization, and the consequences of the imbalance of these components can modulate the inflammatory state of the COPD lung. The complex actions involving immune trigger cells, which activate innate and cell-mediated inflammatory responses, could be responsible for the clinical consequences of irreversible airflow limitation, lung remodelling and emphysema in COPD patients.

Entities:  

Keywords:  B cells; ILCs; NETosis; NK cells; T-lymphocytes; autoimmunity; autophagy; dendritic cells; disability; macrophages; outcome; pyroptosis

Year:  2021        PMID: 32997525      PMCID: PMC7877965          DOI: 10.1080/07853890.2020.1831050

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  143 in total

1.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

2.  Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.

Authors:  Ann R Falsey; Maria A Formica; Patricia A Hennessey; Mary M Criddle; Wayne M Sullender; Edward E Walsh
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

3.  Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes.

Authors:  Monique Gannagé; Dorothee Dormann; Randy Albrecht; Jörn Dengjel; Tania Torossi; Patrick C Rämer; Monica Lee; Till Strowig; Frida Arrey; Gina Conenello; Marc Pypaert; Jens Andersen; Adolfo García-Sastre; Christian Münz
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

4.  Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong.

Authors:  Florence H Y Yap; Pak-Leung Ho; Kwok-Fai Lam; Paul K S Chan; Yeung-Hung Cheng; Joseph S M Peiris
Journal:  J Med Virol       Date:  2004-08       Impact factor: 2.327

5.  Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD.

Authors:  Davinder S Garcha; Sarah J Thurston; Anant R C Patel; Alexander J Mackay; James J P Goldring; Gavin C Donaldson; Timothy D McHugh; Jadwiga A Wedzicha
Journal:  Thorax       Date:  2012-08-03       Impact factor: 9.139

6.  Lung microbiome dynamics in COPD exacerbations.

Authors:  Zhang Wang; Mona Bafadhel; Koirobi Haldar; Aaron Spivak; David Mayhew; Bruce E Miller; Ruth Tal-Singer; Sebastian L Johnston; Mohammadali Yavari Ramsheh; Michael R Barer; Christopher E Brightling; James R Brown
Journal:  Eur Respir J       Date:  2016-02-25       Impact factor: 16.671

Review 7.  The role of natural killer cells in pulmonary immunosurveillance.

Authors:  Pamela Rose Hesker; Alexander Sasha Krupnick
Journal:  Front Biosci (Schol Ed)       Date:  2013-01-01

8.  Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

Authors:  Philip L Molyneaux; Patrick Mallia; Michael J Cox; Joseph Footitt; Saffron A G Willis-Owen; Daniel Homola; Maria-Belen Trujillo-Torralbo; Sarah Elkin; Onn Min Kon; William O C Cookson; Miriam F Moffatt; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2013-11-15       Impact factor: 21.405

9.  Analysis of the lung microbiome in the "healthy" smoker and in COPD.

Authors:  John R Erb-Downward; Deborah L Thompson; Meilan K Han; Christine M Freeman; Lisa McCloskey; Lindsay A Schmidt; Vincent B Young; Galen B Toews; Jeffrey L Curtis; Baskaran Sundaram; Fernando J Martinez; Gary B Huffnagle
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

Review 10.  COPD immunopathology.

Authors:  Gaetano Caramori; Paolo Casolari; Adam Barczyk; Andrew L Durham; Antonino Di Stefano; Ian Adcock
Journal:  Semin Immunopathol       Date:  2016-05-13       Impact factor: 9.623

View more
  8 in total

Review 1.  Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD.

Authors:  Holly Mitzel; Dakota Brown; Morgan Thomas; Byrne Curl; Mackenzie Wild; Andrea Kelsch; Judge Muskrat; Abulquasem Hossain; Ken Ryan; Olawale Babalola; Madison Burgard; Masfique Mehedi
Journal:  Medicina (Kaunas)       Date:  2022-02-08       Impact factor: 2.430

2.  Moraxella catarrhalis evades neutrophil oxidative stress responses providing a safer niche for nontypeable Haemophilus influenzae.

Authors:  Sonia Nicchi; Fabiola Giusti; Stefano Carello; Sabrina Utrio Lanfaloni; Simona Tavarini; Elisabetta Frigimelica; Ilaria Ferlenghi; Silvia Rossi Paccani; Marcello Merola; Isabel Delany; Vincenzo Scarlato; Domenico Maione; Cecilia Brettoni
Journal:  iScience       Date:  2022-02-17

3.  Exploring the Change of Host and Microorganism in Chronic Obstructive Pulmonary Disease Patients Based on Metagenomic and Metatranscriptomic Sequencing.

Authors:  Jing Yang; Qiang Zhang; Jun Zhang; Yan Ouyang; Zepeng Sun; Xinlong Liu; Feng Qaio; Li-Qun Xu; Yunfei Niu; Jian Li
Journal:  Front Microbiol       Date:  2022-03-16       Impact factor: 5.640

Review 4.  Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment.

Authors:  Jiaqi Li; Huangliang Zheng; Sharon Shui Yee Leung
Journal:  Pharm Res       Date:  2022-09-19       Impact factor: 4.580

5.  Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific.

Authors:  Laura Taddei; Lucio Malvisi; David S Hui; Ludovic Malvaux; Ronnie Z Samoro; Sang Haak Lee; Yiu Cheong Yeung; Yu-Chih Liu; Ashwani Kumar Arora
Journal:  ERJ Open Res       Date:  2022-09-26

6.  Screening and identification of tissue-infiltrating immune cells and genes for patients with emphysema phenotype of COPD.

Authors:  Di Wang; Bingnan Chen; Shuang Bai; Li Zhao
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

Review 7.  Virome in the Lungs: The Role of Anelloviruses in Childhood Respiratory Diseases.

Authors:  Giulia Dodi; Marina Attanasi; Paola Di Filippo; Sabrina Di Pillo; Francesco Chiarelli
Journal:  Microorganisms       Date:  2021-06-23

8.  Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study.

Authors:  Mei Yang; Xuemei Liu; Qiongqiong Hu; Junjie Li; Sijia Fu; Daohong Chen; Yanqing Wu; Ai Luo; Xiawei Zhang; Ruizhi Feng; Guo Xu; Can Liu; Hongli Jiang; Wei Liu
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.